Banco Bilbao Vizcaya Argentaria, S.A. Cidara Therapeutics, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.85 - $4.1 $250,178 - $359,906	-87,782 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.74 - $4.26 $48,340 - $118,351	27,782 Added 46.3%	87,782 $217,000
Q4 2019 Feb 13, 2020	BUY	$1.77 - $3.84 $106,200 - $230,400	60,000 New	60,000 $230,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.88B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.